Resultados de la búsqueda 91-100 of 14464 for Hypercalcaemia

  1. Hiperplasia suprarrenal congénita

    Congenital adrenal hyperplasia (CAH). Eunice Kennedy Shriver National Institute of Child Health and Human Development.

  2. Hematología - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  3. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  4. Enfermedad de las arterias coronarias.

    Publicaciones · Ferri FF. Coronary artery disease. · Coronary heart disease. National Heart, Lung, and Blood Institute. · Usatine RP, et al., eds. · Wilson PWF.

  5. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to analyze the effect of parity, menopause and reproductive lifespan on kidney structure and function. 24-Hydroxylase Deficiency ...

  6. Hematología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to compare the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden.

  7. Hematología - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  8. Hematología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to compare the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden.

  9. Hematología - Ensayos clínicos - Mayo Clinic

    This phase III trial compares the effect of high dose chemotherapy and the patients' own (autologous) stem cells to observation only in patients with ...

  10. Hematología - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to determine how well tafasitamab, lenalidomide and venetoclax work in treating patients with mantle cell lymphoma ...